<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">39346555</PMID><DateRevised><Year>2024</Year><Month>10</Month><Day>01</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">1663-9812</ISSN><JournalIssue CitedMedium="Print"><Volume>15</Volume><PubDate><Year>2024</Year></PubDate></JournalIssue><Title>Frontiers in pharmacology</Title><ISOAbbreviation>Front Pharmacol</ISOAbbreviation></Journal><ArticleTitle>The impact of a multidisciplinary team intervention on medication prescription in nursing homes in Catalonia.</ArticleTitle><Pagination><StartPage>1445141</StartPage><MedlinePgn>1445141</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">1445141</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3389/fphar.2024.1445141</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="UNASSIGNED">In response to the rising population of nursing home residents with frailty and multimorbidity, optimizing medication safety through drug utilization review and addressing medication-related problems (MRPs) is imperative. Clinical decision support systems help reduce medication errors and detect potential MRPs, as well as medication reviews performed by a multidisciplinary team, but these combined assessments are not commonly performed. The objective of this study was to evaluate the impact on medication plans of a multidisciplinary team intervention in nursing homes, by analyzing the medication plan before and after the intervention and assessing whether the recommendations given had been implemented.</AbstractText><AbstractText Label="METHODS" NlmCategory="UNASSIGNED">A multicenter before-after study, involving five nursing homes, assessed the impact of a multidisciplinary team intervention, to estimate effectiveness related to the review of the prescribed medications. The follow-up period for each patient was 12 months or until death if prior, from July 2020 to February 2022, and involved 483 patients. The clinical pharmacologist coordinated the intervention and reviewed all the prescribed medications to make recommendations, focused on the completion of absent data, withdrawal of a drug, verification of whether a drug was adequate, the substitution of a drug, and the addition of drugs. Since the intervention was performed during the COVID-19 pandemic, optimization of psychotropic drugs and absorbent pads were limited.</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">The intervention had an impact with recommendations given for 398 (82.4%) of the patients and which were followed by 58.5% of them. At least one drug was withdrawn in 293 (60.7%) of the patients, with a mean of 2.3 (SD 1.7). As for the total of 1,097 recommendations given, 355 (32.4%) were followed. From the intervention, antipsychotics, antidepressants, benzodiazepines, statins, and diuretics were the most frequently withdrawn.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="UNASSIGNED">The findings underscore the impact of targeted interventions to reduce inappropriate medications and enhance medication safety in nursing homes. The proposed recommendations given and followed show the importance of a multidisciplinary team, coordinated by a clinical pharmacologist, for a patient-centered approach to make medication reviews regularly, with the help of clinical decision support systems, to help reduce potential MRPs and polypharmacy.</AbstractText><CopyrightInformation>Copyright © 2024 Anderssen-Nordahl, Fernández-Liz, Sabaté Gallego, Bosch Ferrer, Sánchez-Arcilla Rosanas, Cervera León, Magrinyà and Barceló-Colomer.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Anderssen-Nordahl</LastName><ForeName>Emilie</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Clinical Pharmacology Service, Vall d'Hebron University Hospital, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Clinical Pharmacology Group, Vall d'Hebron Research Institute, Barcelona, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pharmacology, Therapeutics and Toxicology, Universitat Autònoma de Barcelona, Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fernández-Liz</LastName><ForeName>Eladio</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Primary Healthcare Barcelona, Management of Primary Care and the Community of Barcelona City, Catalan Institute of Health, Barcelona, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Foundation University Institute for Research in Primary Health Care Jordi Gol i Gurina (IDIAPJGol), Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sabaté Gallego</LastName><ForeName>Mònica</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Clinical Pharmacology Service, Vall d'Hebron University Hospital, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Clinical Pharmacology Group, Vall d'Hebron Research Institute, Barcelona, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pharmacology, Therapeutics and Toxicology, Universitat Autònoma de Barcelona, Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bosch Ferrer</LastName><ForeName>Montserrat</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Clinical Pharmacology Service, Vall d'Hebron University Hospital, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Clinical Pharmacology Group, Vall d'Hebron Research Institute, Barcelona, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pharmacology, Therapeutics and Toxicology, Universitat Autònoma de Barcelona, Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sánchez-Arcilla Rosanas</LastName><ForeName>Margarita</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Geriatric Unit, Internal Medicine Service, Vall d'Hebron University Hospital, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cervera León</LastName><ForeName>Mercè</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Primary Healthcare Barcelona, Management of Primary Care and the Community of Barcelona City, Catalan Institute of Health, Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Magrinyà</LastName><ForeName>Joaquim Miquel</ForeName><Initials>JM</Initials><AffiliationInfo><Affiliation>Primary Healthcare Barcelona, Management of Primary Care and the Community of Barcelona City, Catalan Institute of Health, Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Barceló-Colomer</LastName><ForeName>Maria Estrella</ForeName><Initials>ME</Initials><AffiliationInfo><Affiliation>Primary Healthcare Barcelona, Management of Primary Care and the Community of Barcelona City, Catalan Institute of Health, Barcelona, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Foundation University Institute for Research in Primary Health Care Jordi Gol i Gurina (IDIAPJGol), Barcelona, Spain.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>09</Month><Day>13</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Pharmacol</MedlineTA><NlmUniqueID>101548923</NlmUniqueID><ISSNLinking>1663-9812</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">drug utilization review</Keyword><Keyword MajorTopicYN="N">frail elderly</Keyword><Keyword MajorTopicYN="N">nursing homes</Keyword><Keyword MajorTopicYN="N">patient care team</Keyword><Keyword MajorTopicYN="N">potentially inappropriate medication list</Keyword></KeywordList><CoiStatement>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>6</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>8</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>9</Month><Day>30</Day><Hour>16</Hour><Minute>21</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>9</Month><Day>30</Day><Hour>16</Hour><Minute>20</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>9</Month><Day>30</Day><Hour>9</Hour><Minute>53</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>9</Month><Day>13</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39346555</ArticleId><ArticleId IdType="pmc">PMC11427848</ArticleId><ArticleId IdType="doi">10.3389/fphar.2024.1445141</ArticleId><ArticleId IdType="pii">1445141</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>American Geriatrics Society Beers Criteria® Update Expert Panel (2023). American Geriatrics Society 2023 updated AGS Beers Criteria® for potentially inappropriate medication use in older adults. J. Am. Geriatr. Soc. 71, 2052–2081. 10.1111/jgs.18372</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jgs.18372</ArticleId><ArticleId IdType="pubmed">37139824</ArticleId></ArticleIdList></Reference><Reference><Citation>Anderssen-Nordahl E., Sánchez-Arcilla Rosanas M., Bosch Ferrer M., Fernández-Liz E., Fernández-Liz E., San-José A., et al. (2024). Pharmacological treatments and medication-related problems in nursing homes in Catalonia: a multidisciplinary approach. Front. Pharmacol. 15, 1320490. 10.3389/fphar.2024.1320490</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphar.2024.1320490</ArticleId><ArticleId IdType="pmc">PMC10961593</ArticleId><ArticleId IdType="pubmed">38529187</ArticleId></ArticleIdList></Reference><Reference><Citation>
BOE-A-2020-3692 (2020). BOE-A-2020-3692 Real Decreto 463/2020, de 14 de marzo, por el que se declara el estado de alarma para la gestión de la situación de crisis sanitaria ocasionada por el COVID-19. Available at: https://www.boe.es/eli/es/rd/2020/03/14/463 (Accessed May 9, 2024).</Citation></Reference><Reference><Citation>Campins L., Serra-Prat M., Gózalo I., López D., Palomera E., Agustí C., et al. (2017). Randomized controlled trial of an intervention to improve drug appropriateness in community-dwelling polymedicated elderly people. Fam. Pract. 34, 36–42. 10.1093/fampra/cmw073</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/fampra/cmw073</ArticleId><ArticleId IdType="pubmed">27605543</ArticleId></ArticleIdList></Reference><Reference><Citation>Canadell-Vilarrasa L., Palanques-Pastor T., Campabadal-Prats C., Salom-Garrigues C., Conde-Giner S., Bejarano-Romero F. (2024). Impact of a primary care pharmacy unit on the optimization of pharmacological treatment of type 2 diabetic patients. Aten. Primaria 56, 102945. 10.1016/j.aprim.2024.102945</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.aprim.2024.102945</ArticleId><ArticleId IdType="pmc">PMC11061215</ArticleId><ArticleId IdType="pubmed">38663157</ArticleId></ArticleIdList></Reference><Reference><Citation>
Catalan Health Service (2024). Informes de facturació farmacèutica. CatSalut Serv. Català Salut. Available at: http://catsalut.gencat.cat/ca/proveidors-professionals/farmacia-medicaments/prestacio-farmaceutica/informes-facturacio/(Accessed June 3, 2024).</Citation></Reference><Reference><Citation>Catalan Health Service: Department of Health. (2020). Potentially inappropriate medication for the elderly.</Citation></Reference><Reference><Citation>Cole J. A., Gonçalves-Bradley D. C., Alqahtani M., Barry H. E., Cadogan C., Rankin A., et al. (2023). Interventions to improve the appropriate use of polypharmacy for older people. Cochrane Database Syst. Rev. 10, CD008165. 10.1002/14651858.CD008165.pub5</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/14651858.CD008165.pub5</ArticleId><ArticleId IdType="pmc">PMC10565901</ArticleId><ArticleId IdType="pubmed">37818791</ArticleId></ArticleIdList></Reference><Reference><Citation>Connors M. H., Ames D., Boundy K., Clarnette R., Kurrle S., Mander A., et al. (2016). Predictors of mortality in dementia: the PRIME study. J. Alzheimers Dis. Jad. 52, 967–974. 10.3233/JAD-150946</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/JAD-150946</ArticleId><ArticleId IdType="pubmed">27079702</ArticleId></ArticleIdList></Reference><Reference><Citation>Cooper J. A., Cadogan C. A., Patterson S. M., Kerse N., Bradley M. C., Ryan C., et al. (2015). Interventions to improve the appropriate use of polypharmacy in older people: a Cochrane systematic review. BMJ Open 5, e009235. 10.1136/bmjopen-2015-009235</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2015-009235</ArticleId><ArticleId IdType="pmc">PMC4679890</ArticleId><ArticleId IdType="pubmed">26656020</ArticleId></ArticleIdList></Reference><Reference><Citation>Curtin D., Jennings E., Daunt R., Curtin S., Randles M., Gallagher P., et al. (2020). Deprescribing in older people approaching end of life: a randomized controlled trial using STOPPFrail criteria. J. Am. Geriatr. Soc. 68, 762–769. 10.1111/jgs.16278</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jgs.16278</ArticleId><ArticleId IdType="pubmed">31868920</ArticleId></ArticleIdList></Reference><Reference><Citation>Dalleur O., Boland B., Losseau C., Henrard S., Wouters D., Speybroeck N., et al. (2014). Reduction of potentially inappropriate medications using the STOPP criteria in frail older inpatients: a randomised controlled study. Drugs Aging 31, 291–298. 10.1007/s40266-014-0157-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40266-014-0157-5</ArticleId><ArticleId IdType="pubmed">24566877</ArticleId></ArticleIdList></Reference><Reference><Citation>
Department of Health, Government of Catalonia (2014). Management of medication in the chronic patient: conciliation, review, deprescription and adherence. Chronic Prev. care program. 
https://scientiasalut.gencat.cat/bitstream/handle/11351/1477/rational_use_global_eng_2015.pdf?sequence=2&amp;isAllowed=y

</Citation></Reference><Reference><Citation>Des Jarlais D. C., Lyles C., Crepaz N. TREND Group (2004). Improving the reporting quality of nonrandomized evaluations of behavioral and public health interventions: the TREND statement. Am. J. Public Health 94, 361–366. 10.2105/ajph.94.3.361</Citation><ArticleIdList><ArticleId IdType="doi">10.2105/ajph.94.3.361</ArticleId><ArticleId IdType="pmc">PMC1448256</ArticleId><ArticleId IdType="pubmed">14998794</ArticleId></ArticleIdList></Reference><Reference><Citation>Disalvo D., Luckett T., Bennett A., Davidson P. M., Agar M. (2020). Multidisciplinary perspectives on medication-related decision-making for people with advanced dementia living in long-term care: a critical incident analysis. Eur. J. Clin. Pharmacol. 76, 567–578. 10.1007/s00228-019-02820-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00228-019-02820-z</ArticleId><ArticleId IdType="pubmed">31932874</ArticleId></ArticleIdList></Reference><Reference><Citation>Duong M. H., McLachlan A. J., Bennett A. A., Jokanovic N., Le Couteur D. G., Baysari M. T., et al. (2021). Iterative development of clinician guides to support deprescribing decisions and communication for older patients in hospital: a novel methodology. Drugs Aging 38, 75–87. 10.1007/s40266-020-00820-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40266-020-00820-8</ArticleId><ArticleId IdType="pubmed">33251567</ArticleId></ArticleIdList></Reference><Reference><Citation>Falster M. O., Charrier R., Pearson S.-A., Buckley N. A., Daniels B. (2021). Long-term trajectories of medicine use among older adults experiencing polypharmacy in Australia. Br. J. Clin. Pharmacol. 87, 1264–1274. 10.1111/bcp.14504</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/bcp.14504</ArticleId><ArticleId IdType="pubmed">32737910</ArticleId></ArticleIdList></Reference><Reference><Citation>Faulkner L., Hughes C. M., Barry H. E. (2022). Interventions to improve medicines optimisation in older people with frailty in primary care: a systematic review. Int. J. Pharm. Pract. 30, 297–304. 10.1093/ijpp/riac036</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ijpp/riac036</ArticleId><ArticleId IdType="pubmed">35532337</ArticleId></ArticleIdList></Reference><Reference><Citation>Fog A. F., Kvalvaag G., Engedal K., Straand J. (2017). Drug-related problems and changes in drug utilization after medication reviews in nursing homes in Oslo, Norway. Scand. J. Prim. Health Care 35, 329–335. 10.1080/02813432.2017.1397246</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/02813432.2017.1397246</ArticleId><ArticleId IdType="pmc">PMC5730030</ArticleId><ArticleId IdType="pubmed">29096573</ArticleId></ArticleIdList></Reference><Reference><Citation>Garfinkel D., Bilek A. (2020). Inappropriate medication use and polypharmacy in older people. BMJ 369, m2023. 10.1136/bmj.m2023</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.m2023</ArticleId><ArticleId IdType="pubmed">32554409</ArticleId></ArticleIdList></Reference><Reference><Citation>Ibrahim K., Cox N. J., Stevenson J. M., Lim S., Fraser S. D. S., Roberts H. C. (2021). A systematic review of the evidence for deprescribing interventions among older people living with frailty. BMC Geriatr. 21, 258. 10.1186/s12877-021-02208-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12877-021-02208-8</ArticleId><ArticleId IdType="pmc">PMC8052791</ArticleId><ArticleId IdType="pubmed">33865310</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim D.-S., Je N. K., Park J., Lee S. (2021). Effect of nationwide concurrent drug utilization review program on drug-drug interactions and related health outcome. Int. J. Qual. Health Care J. Int. Soc. Qual. Health Care 33, mzab118. 10.1093/intqhc/mzab118</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/intqhc/mzab118</ArticleId><ArticleId IdType="pubmed">34402911</ArticleId></ArticleIdList></Reference><Reference><Citation>Kojima G. (2015). Prevalence of frailty in nursing homes: a systematic review and meta-analysis. J. Am. Med. Dir. Assoc. 16, 940–945. 10.1016/j.jamda.2015.06.025</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jamda.2015.06.025</ArticleId><ArticleId IdType="pubmed">26255709</ArticleId></ArticleIdList></Reference><Reference><Citation>Kua C.-H., Mak V. S. L., Huey Lee S. W. (2019). Health outcomes of deprescribing interventions among older residents in nursing homes: a systematic review and meta-analysis. J. Am. Med. Dir. Assoc. 20, 362–372. 10.1016/j.jamda.2018.10.026</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jamda.2018.10.026</ArticleId><ArticleId IdType="pubmed">30581126</ArticleId></ArticleIdList></Reference><Reference><Citation>Kurczewska-Michalak M., Lewek P., Jankowska-Polańska B., Giardini A., Granata N., Maffoni M., et al. (2021). Polypharmacy management in the older adults: a scoping review of available interventions. Front. Pharmacol. 12, 734045. 10.3389/fphar.2021.734045</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphar.2021.734045</ArticleId><ArticleId IdType="pmc">PMC8661120</ArticleId><ArticleId IdType="pubmed">34899294</ArticleId></ArticleIdList></Reference><Reference><Citation>Lavan A. H., Gallagher P. F., O’Mahony D. (2016). Methods to reduce prescribing errors in elderly patients with multimorbidity. Clin. Interv. Aging 11, 857–866. 10.2147/CIA.S80280</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/CIA.S80280</ArticleId><ArticleId IdType="pmc">PMC4922820</ArticleId><ArticleId IdType="pubmed">27382268</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma X., Yin X., Li M., Wang Y., Xin H., Liu W. (2021). Appropriate use of essential medicines in the elderly: a comparison of the WHO essential medicines list and PIM criteria. Eur. J. Clin. Pharmacol. 77, 509–516. 10.1007/s00228-020-03038-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00228-020-03038-0</ArticleId><ArticleId IdType="pubmed">33180148</ArticleId></ArticleIdList></Reference><Reference><Citation>Mann N.-K., Mathes T., Sönnichsen A., Pieper D., Klager E., Moussa M., et al. (2023). Potentially inadequate medications in the elderly: PRISCUS 2.0. Dtsch. Arzteblatt Int. 120, 3–10. 10.3238/arztebl.m2022.0377</Citation><ArticleIdList><ArticleId IdType="doi">10.3238/arztebl.m2022.0377</ArticleId><ArticleId IdType="pmc">PMC10035347</ArticleId><ArticleId IdType="pubmed">36507719</ArticleId></ArticleIdList></Reference><Reference><Citation>Mok P. L. H., Carr M. J., Guthrie B., Morales D. R., Sheikh A., Elliott R. A., et al. (2024). Multiple adverse outcomes associated with antipsychotic use in people with dementia: population based matched cohort study. BMJ 385, e076268. 10.1136/bmj-2023-076268</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj-2023-076268</ArticleId><ArticleId IdType="pmc">PMC11022137</ArticleId><ArticleId IdType="pubmed">38631737</ArticleId></ArticleIdList></Reference><Reference><Citation>Morin L., Laroche M.-L., Texier G., Johnell K. (2016). Prevalence of potentially inappropriate medication use in older adults living in nursing homes: a systematic review. J. Am. Med. Dir. Assoc. 17, 862.e1–e9. 10.1016/j.jamda.2016.06.011</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jamda.2016.06.011</ArticleId><ArticleId IdType="pubmed">27473899</ArticleId></ArticleIdList></Reference><Reference><Citation>NICE guideline (2016). Multimorbidity: clinical assessment and management.</Citation></Reference><Reference><Citation>O’Mahony D., Cherubini A., Guiteras A. R., Denkinger M., Beuscart J.-B., Onder G., et al. (2023). STOPP/START criteria for potentially inappropriate prescribing in older people: version 3. Eur. Geriatr. Med. 14, 625–632. 10.1007/s41999-023-00777-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s41999-023-00777-y</ArticleId><ArticleId IdType="pmc">PMC10447584</ArticleId><ArticleId IdType="pubmed">37256475</ArticleId></ArticleIdList></Reference><Reference><Citation>Osmani F., Arab-Zozani M., Shahali Z., Lotfi F. (2023). Evaluation of the effectiveness of electronic prescription in reducing medical and medical errors (systematic review study). Ann. Pharm. Fr. 81, 433–445. 10.1016/j.pharma.2022.12.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pharma.2022.12.002</ArticleId><ArticleId IdType="pmc">PMC9737496</ArticleId><ArticleId IdType="pubmed">36513154</ArticleId></ArticleIdList></Reference><Reference><Citation>Peral Bolaños C., Santaolalla García I., Gómez Valbuena I., Vega Ruíz L., Iglesias Carabias C., Martín Valero R., et al. (2024). Pharmacological intervention in the medication review of institutionalised elderly patients under polypharmacy. Aten. Primaria 56, 102959. 10.1016/j.aprim.2024.102959</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.aprim.2024.102959</ArticleId><ArticleId IdType="pmc">PMC11126877</ArticleId><ArticleId IdType="pubmed">38763097</ArticleId></ArticleIdList></Reference><Reference><Citation>Pons-Mesquida M. À., Oms-Arias M., Diogène-Fadini E., Figueras A. (2021). Safer prescription of drugs: impact of the PREFASEG system to aid clinical decision-making in primary care in Catalonia. BMC Med. Inf. Decis. Mak. 21, 349. 10.1186/s12911-021-01710-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12911-021-01710-8</ArticleId><ArticleId IdType="pmc">PMC8675496</ArticleId><ArticleId IdType="pubmed">34911534</ArticleId></ArticleIdList></Reference><Reference><Citation>Pons-Mesquida M. À., Oms-Arias M., Figueras A., Diogène-Fadini E. (2022). Impact of a system to assist in clinical decision-making in primary healthcare in Catalonia: prescription Self Audit. BMC Med. Inf. Decis. Mak. 22, 70. 10.1186/s12911-022-01809-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12911-022-01809-6</ArticleId><ArticleId IdType="pmc">PMC8934479</ArticleId><ArticleId IdType="pubmed">35305620</ArticleId></ArticleIdList></Reference><Reference><Citation>
Primary Care Clinical Station (2024). Estació clínica d’Atenció primària (ECAP). Dep. Salut. Available at: http://salutweb.gencat.cat/ca/ambits-actuacio/linies/tic/sistemes-informacio/gestio-assistencial/ecap/(Accessed August 23, 2024).</Citation></Reference><Reference><Citation>Rankin A., Cadogan C. A., Patterson S. M., Kerse N., Cardwell C. R., Bradley M. C., et al. (2018). Interventions to improve the appropriate use of polypharmacy for older people. Cochrane Database Syst. Rev. 9, CD008165. 10.1002/14651858.CD008165.pub4</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/14651858.CD008165.pub4</ArticleId><ArticleId IdType="pmc">PMC6513645</ArticleId><ArticleId IdType="pubmed">30175841</ArticleId></ArticleIdList></Reference><Reference><Citation>Saeed D., Carter G., Parsons C. (2022). Interventions to improve medicines optimisation in frail older patients in secondary and acute care settings: a systematic review of randomised controlled trials and non-randomised studies. Int. J. Clin. Pharm. 44, 15–26. 10.1007/s11096-021-01354-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11096-021-01354-8</ArticleId><ArticleId IdType="pmc">PMC8866367</ArticleId><ArticleId IdType="pubmed">34800255</ArticleId></ArticleIdList></Reference><Reference><Citation>Salom-Garrigues C., Aragonès E., Giralt M., Campabadal Prats C., Bejarano-Romero F., Canadell L. (2024). Evaluation of a pharmacist-led intervention to reduce drug-related problems in patients included in a home healthcare program: study protocol for a pragmatic randomized clinical trial. BMC Geriatr. 24, 170. 10.1186/s12877-024-04763-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12877-024-04763-2</ArticleId><ArticleId IdType="pmc">PMC10875819</ArticleId><ArticleId IdType="pubmed">38373937</ArticleId></ArticleIdList></Reference><Reference><Citation>San-José A., Pérez-Bocanegra C., Agustí A., Laorden H., Gost J., Vidal X., et al. (2021). Integrated health intervention on polypharmacy and inappropriate prescribing in elderly people with multimorbidity: results at the end of the intervention and at 6 months after the intervention. Med. Clin. (Barc.) 156, 263–269. 10.1016/j.medcli.2020.04.030</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.medcli.2020.04.030</ArticleId><ArticleId IdType="pubmed">32593414</ArticleId></ArticleIdList></Reference><Reference><Citation>Schwertner E., Secnik J., Garcia-Ptacek S., Johansson B., Nagga K., Eriksdotter M., et al. (2019). Antipsychotic treatment associated with increased mortality risk in patients with dementia. A registry-based observational cohort study. J. Am. Med. Dir. Assoc. 20, 323–329. 10.1016/j.jamda.2018.12.019</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jamda.2018.12.019</ArticleId><ArticleId IdType="pubmed">30824220</ArticleId></ArticleIdList></Reference><Reference><Citation>Sluggett J. K., Caughey G. E., Air T., Moldovan M., Lang C., Martin G., et al. (2022). Provision of a comprehensive medicines review is associated with lower mortality risk for residents of aged care facilities: a retrospective cohort study. Age Ageing 51, afac149. 10.1093/ageing/afac149</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ageing/afac149</ArticleId><ArticleId IdType="pmc">PMC9259960</ArticleId><ArticleId IdType="pubmed">35794851</ArticleId></ArticleIdList></Reference><Reference><Citation>Song Y., Chen L., Liu Y., Xia X., Hou L., Wu J., et al. (2023). Geriatrician-led multidisciplinary team management improving polypharmacy among older inpatients in China. Front. Pharmacol. 14, 1167306. 10.3389/fphar.2023.1167306</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphar.2023.1167306</ArticleId><ArticleId IdType="pmc">PMC10177397</ArticleId><ArticleId IdType="pubmed">37188273</ArticleId></ArticleIdList></Reference><Reference><Citation>Spinewine A., Evrard P., Hughes C. (2021). Interventions to optimize medication use in nursing homes: a narrative review. Eur. Geriatr. Med. 12, 551–567. 10.1007/s41999-021-00477-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s41999-021-00477-5</ArticleId><ArticleId IdType="pmc">PMC8149362</ArticleId><ArticleId IdType="pubmed">33751478</ArticleId></ArticleIdList></Reference><Reference><Citation>Stuhec M., Zorjan K. (2022). Clinical pharmacist interventions in ambulatory psychogeriatric patients with excessive polypharmacy. Sci. Rep. 12, 11387. 10.1038/s41598-022-15657-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-022-15657-x</ArticleId><ArticleId IdType="pmc">PMC9259566</ArticleId><ArticleId IdType="pubmed">35794225</ArticleId></ArticleIdList></Reference><Reference><Citation>Troncoso-Mariño A., López-Jiménez T., Roso-Llorach A., Villén N., Amado-Guirado E., Guisado-Clavero M., et al. (2021). Medication-related problems in older people in Catalonia: a real-world data study. Pharmacoepidemiol. Drug Saf. 30, 220–228. 10.1002/pds.5149</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/pds.5149</ArticleId><ArticleId IdType="pmc">PMC7839740</ArticleId><ArticleId IdType="pubmed">33026123</ArticleId></ArticleIdList></Reference><Reference><Citation>Urbańczyk K., Guntschnig S., Antoniadis V., Falamic S., Kovacevic T., Kurczewska-Michalak M., et al. (2023). Recommendations for wider adoption of clinical pharmacy in Central and Eastern Europe in order to optimise pharmacotherapy and improve patient outcomes. Front. Pharmacol. 14, 1244151. 10.3389/fphar.2023.1244151</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphar.2023.1244151</ArticleId><ArticleId IdType="pmc">PMC10433912</ArticleId><ArticleId IdType="pubmed">37601045</ArticleId></ArticleIdList></Reference><Reference><Citation>Wallerstedt S. M., Kindblom J. M., Nylén K., Samuelsson O., Strandell A. (2014). Medication reviews for nursing home residents to reduce mortality and hospitalization: systematic review and meta-analysis. Br. J. Clin. Pharmacol. 78, 488–497. 10.1111/bcp.12351</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/bcp.12351</ArticleId><ArticleId IdType="pmc">PMC4243900</ArticleId><ArticleId IdType="pubmed">24548138</ArticleId></ArticleIdList></Reference><Reference><Citation>Wouters H., Foster J. M., Ensink A., O’Donnell L. K., Zuidema S. U., Boersma F., et al. (2019). Barriers and facilitators of conducting medication reviews in nursing home residents: a qualitative study. Front. Pharmacol. 10, 1026. 10.3389/fphar.2019.01026</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphar.2019.01026</ArticleId><ArticleId IdType="pmc">PMC6759938</ArticleId><ArticleId IdType="pubmed">31619991</ArticleId></ArticleIdList></Reference><Reference><Citation>Zahlan G., De Clifford-Faugère G., Nguena Nguefack H. L., Guénette L., Pagé M. G., Blais L., et al. (2023). Polypharmacy and excessive polypharmacy among persons living with chronic pain: a cross-sectional study on the prevalence and associated factors. J. Pain Res. 16, 3085–3100. 10.2147/JPR.S411451</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/JPR.S411451</ArticleId><ArticleId IdType="pmc">PMC10505027</ArticleId><ArticleId IdType="pubmed">37719270</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou S., Jia B., Kong J., Zhang X., Lei L., Tao Z., et al. (2022). Drug-induced fall risk in older patients: a pharmacovigilance study of FDA adverse event reporting system database. Front. Pharmacol. 13, 1044744. 10.3389/fphar.2022.1044744</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphar.2022.1044744</ArticleId><ArticleId IdType="pmc">PMC9746618</ArticleId><ArticleId IdType="pubmed">36523498</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>